Ensign Peak Advisors, Inc Y M Abs Therapeutics, Inc. Put Options Transaction History
Ensign Peak Advisors, Inc
- $55.3 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding YMAB
# of Institutions
112Shares Held
27.1MCall Options Held
40.3KPut Options Held
400-
Paradigm Biocapital Advisors LP New York, NY4.24MShares$26.4 Million1.27% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$18.3 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY2.86MShares$17.9 Million12.11% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.19MShares$13.7 Million1.4% of portfolio
-
Vanguard Group Inc Valley Forge, PA2MShares$12.5 Million0.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $273M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...